Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism

Drug resistant strains of the malaria parasite, Plasmodium falciparum, have rendered chloroquine ineffective throughout much of the world. In parts of Africa and Asia, the coordinated shift from chloroquine to other drugs has resulted in the near disappearance of chloroquine-resistant (CQR) parasite...

Full description

Saved in:
Bibliographic Details
Published inPLoS genetics Vol. 10; no. 1; p. e1004085
Main Authors Lewis, Ian A, Wacker, Mark, Olszewski, Kellen L, Cobbold, Simon A, Baska, Katelynn S, Tan, Asako, Ferdig, Michael T, Llinás, Manuel
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.01.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Drug resistant strains of the malaria parasite, Plasmodium falciparum, have rendered chloroquine ineffective throughout much of the world. In parts of Africa and Asia, the coordinated shift from chloroquine to other drugs has resulted in the near disappearance of chloroquine-resistant (CQR) parasites from the population. Currently, there is no molecular explanation for this phenomenon. Herein, we employ metabolic quantitative trait locus mapping (mQTL) to analyze progeny from a genetic cross between chloroquine-susceptible (CQS) and CQR parasites. We identify a family of hemoglobin-derived peptides that are elevated in CQR parasites and show that peptide accumulation, drug resistance, and reduced parasite fitness are all linked in vitro to CQR alleles of the P. falciparum chloroquine resistance transporter (pfcrt). These findings suggest that CQR parasites are less fit because mutations in pfcrt interfere with hemoglobin digestion by the parasite. Moreover, our findings may provide a molecular explanation for the reemergence of CQS parasites in wild populations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: ML IAL MW KLO MTF. Performed the experiments: IAL MW KLO SAC KSB. Analyzed the data: IAL AT ML MTF. Contributed reagents/materials/analysis tools: ML MTF. Wrote the paper: IAL MW ML MTF.
Current address: Kadmon Corporation, LLC, New York, New York, United States of America.
Current address: Department of Biochemistry and Molecular Biology, and Center for Infectious Disease Dynamics, Pennsylvania State University, State College, Pennsylvania, United States of America
The authors have declared that no competing interests exist.
ISSN:1553-7404
1553-7390
1553-7404
DOI:10.1371/journal.pgen.1004085